UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ultra-metal-poor Stars: Spectroscopic Determination of Stellar Atmospheric Parameters Using Iron Non-LTE Line Abundances

The Astrophysical journal, 2017-10, Vol.847 (2), p.142

2017

Volltextzugriff (PDF)

LOTUS: A (Non-) LTE Optimization Tool for Uniform Derivation of Stellar Atmospheric Parameters

The Astronomical journal, 2023-04, Vol.165 (4), p.145

2023

Volltextzugriff (PDF)

The R-Process Alliance: First Magellan/MIKE Release from the Southern Search for R-process-enhanced Stars

The Astrophysical journal, 2020-08, Vol.898 (2), p.150

2020

Volltextzugriff (PDF)

Evidence for an Aspherical Population III Supernova Explosion Inferred from the Hyper-metal-poor Star HE 1327–2326

The Astrophysical journal, 2019-05, Vol.876 (2), p.97

2019

Volltextzugriff (PDF)

Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3509-3516

2013

Volltextzugriff (PDF)

The R-process Alliance: A Nearly Complete R-process Abundance Template Derived from Ultraviolet Spectroscopy of the R-process-enhanced Metal-poor Star HD 222925

The Astrophysical journal. Supplement series, 2022-06, Vol.260 (2), p.27

2022

Volltextzugriff (PDF)

The R-Process Alliance: Chemodynamically Tagged Groups of Halo r-process-enhanced Stars Reveal a Shared Chemical-evolution History

The Astrophysical journal, 2021-02, Vol.908 (1), p.79

2021

Volltextzugriff (PDF)

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524

2013

Volltextzugriff (PDF)

Stellar Abundances at the Center of Early-type Galaxies with Fine Structure

The Astrophysical journal, 2024-06, Vol.968 (2), p.127

2024

Volltextzugriff (PDF)

RAVE J203843.2–002333: The First Highly R-process-enhanced Star Identified in the RAVE Survey

The Astrophysical journal, 2017-07, Vol.844 (1), p.18

2017

Volltextzugriff (PDF)

The R-Process Alliance: Chemodynamically Tagged Groups. II. An Extended Sample of Halo r-process-enhanced Stars

The Astrophysical journal, 2023-01, Vol.943 (1), p.23

2023

Volltextzugriff (PDF)

The R-Process Alliance: 2MASS J22132050–5137385, the Star with the Highest-known r-process Enhancement at [Eu/Fe] = +2.45

The Astrophysical journal, 2024-08, Vol.971 (2), p.158

2024

Volltextzugriff (PDF)

Discovery of a Metal-poor Red Giant Star with the Highest Ultralithium Enhancement

The Astrophysical journal, 2024-10, Vol.973 (2), p.125

2024

Volltextzugriff (PDF)

The R-Process Alliance: Chemical Abundances for a Trio of r-process-enhanced Stars—One Strong, One Moderate, and One Mild

The Astrophysical journal, 2018-09, Vol.864 (1), p.43

2018

Volltextzugriff (PDF)

The R-Process Alliance: Abundance Universality among Some Elements at and between the First and Second R-Process Peaks

The Astrophysical journal, 2022-09, Vol.936 (1), p.84

2022

Volltextzugriff (PDF)

Uranium Abundances and Ages of r-process Enhanced Stars with Novel U ii Lines

The Astrophysical journal, 2023-05, Vol.948 (2), p.122

2023

Volltextzugriff (PDF)

The R-process Alliance: Fifth Data Release from the Search for R-process-enhanced Metal-poor Stars in the Galactic Halo with the GTC

The Astrophysical journal. Supplement series, 2024-10, Vol.274 (2), p.39

2024

Volltextzugriff (PDF)

GTC Follow-up Observations of Very Metal-poor Star Candidates from DESI

The Astrophysical journal, 2023-11, Vol.957 (2), p.76

2023

Volltextzugriff (PDF)

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

Blood, 2007-03, Vol.109 (6), p.2303-2309

2007

Volltextzugriff (PDF)

The R-Process Alliance: Spectroscopic Follow-up of Low-metallicity Star Candidates from the Best & Brightest Survey

The Astrophysical journal, 2019-01, Vol.870 (2), p.122

2019

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3415-3420

2007

Volltextzugriff (PDF)

Revisiting the Iron Abundance in the Hyper Iron-poor Star HE 1327–2326 with UV COS/HST Data

The Astrophysical journal, 2018-08, Vol.863 (2), p.168

2018

Volltextzugriff (PDF)

Revisiting the Iron Abundance in the Hyper Iron-poor Star HE 1327-2326 with UV COS/HST Data Based on observations made with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute (STScI), which is operated by the Association of Universities for Research in Astronomy, Inc. (AURA) under NASA contract NAS 5-26555. These observations are associated with program GO-14151

The Astrophysical journal, 2018-08, Vol.863 (2)

2018

Volltextzugriff (PDF)

Renal insufficiency predicts the time to first appropriate defibrillator shock

The American heart journal, 2006-04, Vol.151 (4), p.852-856

2006

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAstrophysical Journal. Letters

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(71)
Dissertationen
(1)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Ultra-metal-poor Stars: Spectroscopic Determination of Stellar Atmospheric Parameters Using Iron Non-LTE Line Abundances

LOTUS: A (Non-) LTE Optimization Tool for Uniform Derivation of Stellar Atmospheric Parameters

The R-Process Alliance: First Magellan/MIKE Release from the Southern Search for R-process-enhanced Stars

Evidence for an Aspherical Population III Supernova Explosion Inferred from the Hyper-metal-poor Star HE 1327–2326

The R-Process Alliance: First Release from the Northern Search for r-process-enhanced Metal-poor Stars in the Galactic Halo

Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

The R-process Alliance: A Nearly Complete R-process Abundance Template Derived from Ultraviolet Spectroscopy of the R-process-enhanced Metal-poor Star HD 222925

The R-Process Alliance: Chemodynamically Tagged Groups of Halo r-process-enhanced Stars Reveal a Shared Chemical-evolution History

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Stellar Abundances at the Center of Early-type Galaxies with Fine Structure

RAVE J203843.2–002333: The First Highly R-process-enhanced Star Identified in the RAVE Survey

The R-Process Alliance: Chemodynamically Tagged Groups. II. An Extended Sample of Halo r-process-enhanced Stars

The R-Process Alliance: 2MASS J22132050–5137385, the Star with the Highest-known r-process Enhancement at [Eu/Fe] = +2.45

Discovery of a Metal-poor Red Giant Star with the Highest Ultralithium Enhancement

The R-Process Alliance: Chemical Abundances for a Trio of r-process-enhanced Stars—One Strong, One Moderate, and One Mild

The R-Process Alliance: Abundance Universality among Some Elements at and between the First and Second R-Process Peaks

Uranium Abundances and Ages of r-process Enhanced Stars with Novel U ii Lines

The R-process Alliance: Fifth Data Release from the Search for R-process-enhanced Metal-poor Stars in the Galactic Halo with the GTC

GTC Follow-up Observations of Very Metal-poor Star Candidates from DESI

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

The R-Process Alliance: Spectroscopic Follow-up of Low-metallicity Star Candidates from the Best & Brightest Survey

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

Revisiting the Iron Abundance in the Hyper Iron-poor Star HE 1327–2326 with UV COS/HST Data

Renal insufficiency predicts the time to first appropriate defibrillator shock

Aktive Filter

Suchergebnisse filtern